Sentinel Lymph Node Biopsy
"Sentinel Lymph Node Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm.
Descriptor ID |
D021701
|
MeSH Number(s) |
E01.370.225.500.384.100.580 E01.370.225.998.054.580 E01.370.388.100.580 E04.074.580 E04.446.819 E05.200.500.384.100.580 E05.200.998.054.580 E05.242.384.100.580
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node Biopsy".
This graph shows the total number of publications written about "Sentinel Lymph Node Biopsy" by people in this website by year, and whether "Sentinel Lymph Node Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 2 | 2 | 4 |
2001 | 12 | 5 | 17 |
2002 | 12 | 7 | 19 |
2003 | 12 | 6 | 18 |
2004 | 16 | 9 | 25 |
2005 | 22 | 6 | 28 |
2006 | 28 | 6 | 34 |
2007 | 18 | 10 | 28 |
2008 | 20 | 9 | 29 |
2009 | 13 | 14 | 27 |
2010 | 14 | 7 | 21 |
2011 | 20 | 13 | 33 |
2012 | 13 | 12 | 25 |
2013 | 10 | 9 | 19 |
2014 | 20 | 12 | 32 |
2015 | 18 | 7 | 25 |
2016 | 6 | 15 | 21 |
2017 | 11 | 11 | 22 |
2018 | 8 | 10 | 18 |
2019 | 7 | 15 | 22 |
2020 | 10 | 14 | 24 |
2021 | 3 | 17 | 20 |
2022 | 1 | 15 | 16 |
2023 | 0 | 18 | 18 |
2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sentinel Lymph Node Biopsy" by people in Profiles.
-
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):504-509.
-
Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. Eur J Surg Oncol. 2024 Apr; 50(4):108245.
-
ASO Author Reflections: Lymph Node Station 16 Status-Becoming a Student of Your Patients' Cancer. Ann Surg Oncol. 2024 May; 31(5):3031-3032.
-
ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 May; 31(5):3196-3197.
-
Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery? Ann Surg Oncol. 2024 May; 31(5):3128-3140.
-
Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery. Breast J. 2023; 2023:9993852.
-
Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors. Ann Surg Oncol. 2024 Mar; 31(3):1623-1633.
-
Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes. J Surg Oncol. 2023 Dec; 128(8):1407-1415.
-
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334.
-
Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review. Int J Gynecol Cancer. 2023 09 04; 33(9):1370-1375.